| Date | Title | Description | Source |
| 11.10.2022 | Headline results from Phase I clinical trial of ultra-rapid ... | Arecor Therapeutics plc
(“Arecor”, the “Company” or the “Group”)
HEADLINE RESULTS FROM PHASE I CLIN... | globenewsw... |
| 01.08.2022 | Arecor Therapeutics raising £6m to acquire diabetes medicine... | - | cambridgea... |
| 14.07.2022 | BUSINESS UPDATE | Arecor Therapeutics plc
(“Arecor” or the “Group”)
BUSINESS UPDATE Pipeline for future revenue gener... | globenewsw... |
| 18.05.2022 | ARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND ... | Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCEN... | globenewsw... |
| 28.04.2022 | ARECOR PRESENTS FULL DATA FROM POSITIVE PHASE I CLINICAL TRI... | ARECOR PRESENTS FULL DATA FROM POSITIVE PHASE I CLINICAL TRIAL OF
AT278 ULTRA-CONCENTRATED ULTRA-RAP... | globenewsw... |
| 12.04.2022 | Arecor Announces Oral Presentation at Attd 2022 of Phase i C... | Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR ANNOUNCES ORAL PRESENTATION AT ATTD 2022 O... | globenewsw... |
| 23.03.2022 | ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULI... | Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIE... | globenewsw... |
| 20.01.2022 | ARECOR COMMENCES US PHASE I CLINICAL TRIAL OF AT247 ULTRA-RA... | Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR COMMENCES US PHASE I CLINICAL TRIAL OF AT2... | globenewsw... |
| 20.01.2022 | BUSINESS UPDATE | Arecor Therapeutics plc
(“Arecor”, the “Company” or the “Group”)
BUSINESS UPDATE
Momentum continues... | globenewsw... |
| 20.01.2022 | ARECOR COMMENCES US PHASE I CLINICAL TRIAL OF AT247 ULTRA-RA... | Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR COMMENCES US PHASE I CLINICAL TRIAL OF AT2... | marketscre... |
| 14.12.2021 | Arecor announces exclusive collaboration with global technol... | Arecor announces exclusive collaboration with global technology leader
14-12-2021
Arecor Therapeut... | cambridgen... |
| 11.11.2021 | Arecor granted key Canadian patent for proprietary technolog... | Arecor granted key Canadian patent for proprietary technology enabling highly concentrated biotherap... | cambridgen... |
| 01.11.2021 | Arecor announces exclusive collaboration with leading global... | Arecor announces exclusive collaboration with leading global medical products company
01-11-2021
A... | cambridgen... |
| 01.11.2021 | ARECOR ANNOUNCES AN EXCLUSIVE FORMULATION STUDY COLLABORATIO... | Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR ANNOUNCES AN EXCLUSIVE FORMULATION STUDY C... | globenewsw... |
| 20.09.2021 | Arecor announces positive headline results from first Phase ... | Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to en... | cambridgen... |
| 20.09.2021 | Arecor Announces Positive Headline Results From First Phase ... | Arecor Therapeutics plc
(“Arecor”, the “Company” or the “Group”)
ARECOR ANNOUNCES POSITIVE HEADLINE... | marketscre... |
| 20.09.2021 | Arecor announces positive headline results from first Phase ... | Arecor announces positive headline results from first Phase I clinical trial of diabetes treatment
... | cambridgen... |
| 27.08.2021 | Arecor announces appointment of Grant Thornton as auditor | Arecor Therapeutics plc (AIM: AREC), a globally focused biopharmaceutical group advancing today’s th... | cambridgen... |
| 27.08.2021 | Arecor announces appointment of Grant Thornton as auditor | Arecor announces appointment of Grant Thornton as auditor
27-08-2021
Arecor Therapeutics plc (AIM:... | cambridgen... |
| 07.06.2021 | Arecor announces exclusive formulation study collaboration w... | Arecor announces exclusive formulation study collaboration with Par
07-06-2021
Arecor Therapeutics... | cambridgen... |
| 03.06.2021 | Arecor market cap soars to c$100m after IPO | Arecor market cap soars to c$100m after IPO
03-06-2021
Cambridge biopharma business Arecor made a ... | cambridgen... |
| 20.05.2021 | Arecor Announces an Exclusive Formulation Study Collaboratio... | CAMBRIDGE, United Kingdom, May 20, 2021 (GLOBE NEWSWIRE) -- Arecor Limited (“Arecor” or “the Company... | marketscre... |
| 31.03.2021 | Arecor receives £2.8 million grant award from Innovate UK | Arecor receives £2.8 million grant award from Innovate UK
31-03-2021
Arecor Limited, the biopharma... | cambridgen... |
| 31.03.2021 | Arecor receives £2.8 million grant award from Innovate UK | Coveted award for Phase II clinical development of lead product, AT247, its next generation ultra-ra... | calculusca... |
| 31.03.2021 | Arecor Receives £2.8 Million Grant Award From Innovate UK | CAMBRIDGE, United Kingdom, March 31, 2021 (GLOBE NEWSWIRE) -- Arecor Limited ("Arecor" or ... | marketscre... |
| 31.03.2021 | Arecor receives £2.8 million grant award from Innovate UK | Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives,... | cambridgen... |
| 17.12.2020 | Arecor’s partner Inhibrx exercises its option to license a n... | Arecor’s partner Inhibrx exercises its option to license a new formulation
17-12-2020
Arecor Ltd ,... | cambridgen... |
| 16.12.2020 | Arecor announces publication of Phase I data for AT247 in di... | Arecor announces publication of Phase I data for AT247 in diabetes care
16-12-2020
Arecor Limited,... | cambridgen... |
| 16.12.2020 | Arecor announces publication of Phase I data for AT247 in di... | Arecor Limited,, the biopharmaceutical company advancing today’s therapies to enable healthier lives... | cambridgen... |
| 15.06.2020 | ARECOR presents positive results for the first Phase I clini... | ARECOR presents positive results for the first Phase I clinical trial of novel insulin formulation
... | cambridgen... |
| 19.03.2020 | Arecor extends multi-product collaboration with clinical sta... | Arecor extends multi-product collaboration with clinical stage biotech
19-03-2020
Arecor Limited, ... | cambridgen... |
| 25.02.2020 | Arecor achieves second licence milestone payment from global... | Arecor achieves second licence milestone payment from global pharmaceutical partner
25-02-2020
Are... | cambridgen... |
| 05.12.2019 | Arecor announces positive headline results for first Phase I... | Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives,... | cambridgen... |
| 05.12.2019 | Arecor announces positive headline results for first Phase I... | Arecor announces positive headline results for first Phase I clinical trial of AT247, a novel formul... | cambridgen... |
| 22.10.2019 | Arecor and JDRF sign a joint research, development and comme... | Arecor and JDRF sign a joint research, development and commercialisation agreement
22-10-2019
Arec... | cambridgen... |
| 03.05.2019 | Arecor signs new multi-product collaboration with major glob... | Arecor signs new multi-product collaboration with major global pharmaceutical company
03-05-2019
A... | cambridgen... |
| 11.03.2019 | Arecor appoints Chief Financial Officer | Arecor appoints Chief Financial Officer
11-03-2019
Arecor Limited, the specialty pharmaceutical co... | cambridgen... |
| 13.02.2019 | Super-fast-acting prandial insulin product receives £0.5m In... | Super-fast-acting prandial insulin product receives £0.5m Innovate UK boost
13-02-2019
Arecor Ltd,... | cambridgen... |
| 13.02.2019 | Super-fast-acting prandial insulin product receives £0.5m In... | Arecor Ltd, the specialty pharmaceutical company leveraging its innovative and proprietary formulati... | cambridgen... |
| 10.01.2019 | Arecor participates in PepTalk 2019’s Protein Science week i... | Arecor participates in PepTalk 2019’s Protein Science week in San Diego, CA, USA
10-01-2019
Arecor... | cambridgen... |
| 14.12.2018 | Arecor attends the 37TH annual JP Morgan Healthcare Conferen... | Arecor attends the 37TH annual JP Morgan Healthcare Conference
14-12-2018
Arecor Ltd, the UK-based... | cambridgen... |
| 31.10.2018 | Arecor successfully defends a key European Patent | Arecor successfully defends a key European Patent
31-10-2018
Arecor successfully defends a key Eur... | cambridgen... |
| 11.09.2018 | Biopharma Formulation Company Arecor Raises £6M | Arecor, a Chesterford Research Park, Little Chesterford, Saffron Walden, UK-based biopharmaceutical ... | finsmes.co... |
| 10.09.2018 | Arecor secures £6m investment for clinical development of it... | Arecor secures £6m investment for clinical development of its diabetes portfolio
10-09-2018
Arecor... | cambridgen... |
| 18.06.2018 | Arecor secures grant to advance co-formulation of critical p... | Innovate UK grant of nearly £1 million will be used to significantly advance Arecor’s proprietary co... | cambridgen... |
| 18.06.2018 | Arecor secures grant to advance co-formulation of critical p... | Arecor secures grant to advance co-formulation of critical pharmaceutical products
18-06-2018
Inno... | cambridgen... |
| 10.01.2018 | Arecor launches new website | Arecor launches new website
10-01-2018
Arecor Ltd, the leading formulation technology company focu... | cambridgen... |
| 10.01.2018 | Arecor launches new website | Arecor Ltd, the leading formulation technology company focused on developing superior biopharmaceuti... | cambridgen... |
| 08.01.2018 | European patent on the horizon for Arecor’s proprietary tech... | European patent on the horizon for Arecor’s proprietary technology
08-01-2018
Arecor Ltd is please... | cambridgen... |
| 04.01.2018 | Arecor and JDRF announce successful pre-clinical development... | Arecor and JDRF announce successful pre-clinical development of diabetes treatment
04-01-2018
Arec... | cambridgen... |
| 03.10.2017 | Arecor announces license agreement with global pharmaceutica... | Arecor announces license agreement with global pharmaceutical company
03-10-2017
Arecor Ltd (“the ... | cambridgen... |
| 12.09.2017 | Arecor announces the inaugural formation of a global diabete... | Arecor announces the inaugural formation of a global diabetes Scientific Advisory Board
12-09-2017
... | cambridgen... |
| 25.07.2016 | Arecor partners with JDRF to develop novel diabetes treatmen... | Arecor partners with JDRF to develop novel diabetes treatment
25-07-2016
JDRF announces partnershi... | cambridgen... |
| 12.11.2015 | Arecor, CPI and FUJIFILM Diosynth Biotechnologies collaborat... | Arecor, CPI and FUJIFILM Diosynth Biotechnologies collaborate
12-11-2015
Arecor, CPI and FUJIFILM ... | cambridgen... |
| 12.06.2015 | Arecor CEO announces resignation | Arecor CEO announces resignation
12-06-2015
Thomas Saylor is retiring as CEO of Arecor, the positi... | cambridgen... |
| 12.06.2015 | Arecor CEO announces resignation | Thomas Saylor is retiring as CEO of Arecor, the position in which he has effectively served for the ... | cambridgen... |
| 31.07.2014 | Arecor awarded TSB grant to support expanded protein stabili... | Arecor awarded TSB grant to support expanded protein stability platform
31-07-2014
Arecor Limited ... | cambridgen... |
| 24.06.2014 | GALVmed-Arecor collaborate to pursue new vaccine formulation... | GALVmed-Arecor collaborate to pursue new vaccine formulations for developing world livestock
24-06-... | cambridgen... |
| 18.06.2014 | CPI collaborate with Arecor to enhance compatibility of biol... | CPI collaborate with Arecor to enhance compatibility of biologic medicines with containers
18-06-20... | cambridgen... |
| 29.10.2013 | Arecor launches new platform tool for viscosity reduction in... | Arecor launches new platform tool for viscosity reduction in high concentration biologics
29-10-201... | cambridgen... |
| 29.10.2013 | Arecor launches new platform tool for viscosity reduction in... | Arecor, the Cambridge biotechnology company specialising in the stabilisation of biopharmaceuticals,... | cambridgen... |
| 16.07.2013 | Arecor granted key US patent for metalloprotein stabilisatio... | Arecor granted key US patent for metalloprotein stabilisation
16-07-2013
Arecor, the Cambridge bio... | cambridgen... |
| 25.04.2013 | Arecor patents ground breaking heat stable adenovirus vaccin... | Arecor patents ground breaking heat stable adenovirus vaccine technology
25-04-2013
Arecor announc... | cambridgen... |
| 29.03.2013 | Science Minister David Willetts visits Arecor | Science Minister David Willetts visits Arecor
29-03-2013
Science Minister David Willetts this week... | cambridgen... |
| - | First Day of Dealings on AIM for Arecor | We are delighted to share Arecor's announcement of its first day of dealings on AIM.
Arecor is part... | downing.co... |
| - | The time to put the spotlight on Healthcare is now | As Covid-19 continues to dominate the global agenda, early-stage UK technology companies in the heal... | downing.co... |
| - | BGF explains: our approach to quoted investments | BGF, which has invested in public markets since 2014, has seen a significant step up in activity sin... | bgf.co.uk/... |
